ADD ANI AS A TRUSTED SOURCE
googleads
Menu
Science

Study finds abnormally low levels of key protein in brains of young men with autism

Washington D.C. [USA], Feb 22 (ANI): Researchers using cutting-edge imaging technology have shown that the brains of young men with autism spectrum disorder (ASD) have low levels of a protein that appears to play a role in inflammation and metabolism.

ANI Feb 22, 2020 18:10 IST googleads

ASD is a developmental disorder that emerges in early childhood and is characterised by difficulty communicating and interacting with others.

Washington D.C. [USA], Feb 22 (ANI): Researchers using cutting-edge imaging technology have shown that the brains of young men with autism spectrum disorder (ASD) have low levels of a protein that appears to play a role in inflammation and metabolism.
This surprising discovery was published in the journal Molecular Psychiatry.
The study provides an important new insight into the possible origins of ASD, which affects one in 59 children.
ASD is a developmental disorder that emerges in early childhood and is characterised by difficulty communicating and interacting with others. While the cause is unknown, growing evidence has linked ASD to inflammation of brain tissue, or neuroinflammation.
One sign of neuroinflammation is elevated levels of a substance called translocator protein (TSPO), which can be measured and located in the brain using positron-emission tomography (PET) and anatomical magnetic resonance imaging (MRI).
The MGH study, led by Nicole Zurcher, PhD, an investigator in MGH's Athinoula A. Martinos Center for Biomedical Imaging, was the first to use a new generation of PET "tracers," which more accurately detect TSPO, to examine the brains of people with ASD.
In the study, Zurcher and her colleagues scanned the brains of 15 young adult males (average age, 24) with ASD. The group included both high- and low-functioning subjects with varying degrees of intellectual abilities.
For comparison, Zurcher's team scanned the brains of 18 healthy control subjects who were similar in age. The investigators hypothesized that the scans would show increased levels, or expression, of TSPO in subjects who have ASD.
"To our surprise, that's not what we saw," says Zurcher. Instead, the scans showed that the brains of males with ASD had lower levels of TSPO than those of the healthy subjects. In fact, the men with the most severe symptoms of ASD tended to have the lowest expression of TSPO.
When the tests were repeated several months later, the pattern persisted. The brain regions found to have low expression of TSPO have previously been linked to ASD in earlier studies, and are believed to govern social and cognitive capacities such as processing of emotions, interpreting facial expressions, empathy, and relating to others.
"We know these brain regions are involved in autism," says Zurcher.
To understand this unexpected finding, Zurcher notes that TSPO does more than serve as a marker of inflammation.
"It has multiple complex roles," she says, and some actually promote brain health. For example, adequate TSPO is necessary for normal functioning of mitochondria, which are the "power houses" in cells that produce energy. Earlier research has linked malfunctioning mitochondria in brain cells to ASD. (ANI)

Get the App

What to Read Next

Science

Study gives insights into possible cause of Alzheimer’s disease

Study gives insights into possible cause of Alzheimer’s disease

Researchers at Case Western Reserve University will investigate the possibility that specific brain proteins are involved in the onset of Alzheimer's disease.

Read More
Science

Obesity in mothers doubles risk of autism in babies

Obesity in mothers doubles risk of autism in babies

The University of South Australia has published new research showing that children born to obese mothers both before and during pregnancy are more likely to experience neuropsychiatric and behavioural disorders, such as attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD).

Read More
Science

'Bone marrow cancer drug shows success in blood disorder'

'Bone marrow cancer drug shows success in blood disorder'

When researchers discovered enough proof that a medication used to treat bone marrow cancer and Kaposi sarcoma is safe and effective in treating hereditary hemorrhagic telangiectasia (HHT), a rare bleeding disorder that affects 1 in 5,000 people worldwide, they decided to terminate an early clinical trial funded by the National Institutes of Health

Read More
Science

Study finds how skin cancer occurrence in young adults declines

Study finds how skin cancer occurrence in young adults declines

A recent study suggested that the risk of malignant melanoma, or skin cancer, may be declining in Sweden, at least for people under the age of 50.

Read More
Science

Cancer drug may ease cognitive function for some with autism

Cancer drug may ease cognitive function for some with autism

According to recent research from the University of California San Diego, people with Rett syndrome, a rare disorder linked to autism, may find it easier to think when taking an experimental cancer treatment. This finding could lead to medicines for patients with other neurological conditions.

Read More
Home About Us Our Products Advertise Contact Us Terms & Condition Privacy Policy

Copyright © aninews.in | All Rights Reserved.